Immunohistochemical expression of stem cell markers in pheochromocytomas/paragangliomas is associated with SDHx mutations

European Journal of Endocrinology

Volumn 173, Issue 1, 2015, Pages 43-52

  Oudijk, L ^a   Neuhofer, C M ^b   Lichtenauer, U D ^b   Papathomas, T G ^a   Korpershoek, E ^a   Stoop, H ^a   Oosterhuis, J W ^a   Smid, M ^a   Restuccia, D F ^a   Robledo, M ^c   De Cubas, A A ^c   Mannelli, M ^d   Gimenez Roqueplo, A P ^e,f,g   Dinjens, W N M ^a   Beuschlein, F ^b   De Krijger, R R ^a,h  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Structural Biology and Biocomputing Programme   (Spain)

^d UNIVERSITY OF FLORENCE   (Italy)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CELL MARKER; CHROMOGRANIN A; NERVE GROWTH FACTOR RECEPTOR; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; PREF 1 PROTEIN; PROTEIN LIN28; STEM CELL FACTOR RECEPTOR; SUCCINATE DEHYDROGENASE; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; CANCER STEM CELL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYONIC STEM CELL; FEMALE; GENE; GENE MUTATION; GENOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL; MIDDLE AGED; NEURAL STEM CELL; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SDH GENE; SDHA GENE; SDHB GENE; SDHC GENE; SDHD GENE; TISSUE MICROARRAY; TUMOR VOLUME; ADRENAL TUMOR; AGED; CLINICAL TRIAL; EUROPE; GENETICS; METABOLISM; MICROARRAY ANALYSIS; MULTICENTER STUDY; MUTATION; STEM CELL;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; EUROPE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUTATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA; RECEPTORS, NERVE GROWTH FACTOR; STEM CELLS; SUCCINATE DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84935120768     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-1164     Document Type: Article

References (38)

1. Lenders JW, Eisenhofer G, Mannelli M & Pacak K. Phaeochromocytoma. Lancet 2005 366 665-675. (doi:10.1016/S0140-6736(05)67139-5)
2. Dahia PL. Novel hereditary forms of pheochromocytomas and paragangliomas. Frontiers of Hormone Research 2013 41 79-91. (doi:10.1159/000345671)
3. Fishbein L, Merrill S, Fraker DL, Cohen DL & Nathanson KL. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Annals of Surgical Oncology 2013 20 1444-1450. (doi:10.1245/s10434-013-2942-5)
4. Lorenzo FR, Yang C, Ng Tang Fui M, Vankayalapati H, Zhuang Z, Huynh T, Grossmann M, Pacak K & Prchal JT. A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma. Journal of Molecular Medicine 2013 91 507-512. (doi:10.1007/s00109-012-0967-z)
5. Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, Galateau-Salle F, Feunteun J, Pouysségur J, Richard S & Gardie B. PHD2 mutation and congenital erythrocytosis with paraganglioma. New England Journal of Medicine 2008 359 2685-2692. (doi:10.1056/NEJMoa0806277)
6. Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL et al. The kinesin KIF1Bb acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes and Development 2008 22 884-893. (doi:10.1101/gad.1648608)
7. Crona J, Delgado Verdugo A, Maharjan R, Stalberg P, Granberg D, Hellman P & Björklund P. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. Journal of Clinical Endocrinology and Metabolism 2013 98 E1266-E1271. (doi:10.1210/jc.2012-4257)
8. Letouze E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 2013 23 739-752. (doi:10.1016/j.ccr.2013.04.018)
9. Yang C, Zhuang Z, Fliedner SM, Shankavaram U, Sun MG, Bullova P, Zhu R, Elkahloun AG, Kourlas PJ, Merino M et al. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/ paraganglioma-polycythemia. Journal of Molecular Medicine 2014 93 93-104. (doi:10.1007/s00109-014-1205-7)
10. Goffredo P, Sosa JA & Roman SA. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades. Journal of Surgical Oncology 2013 107 659-664. (doi:10.1002/jso.23297)
11. Cooper GM. The Cell: A Molecular Approach from: The Development and Causes of Cancer (chapter 15). Sunderland: Sinauer Associates, 2000.
12. Jordan CT, Guzman ML & Noble M. Cancer stem cells. New England Journal of Medicine 2006 355 1253-1261. (doi:10.1056/NEJMra061808)
13. Fisher R, Pusztai L & Swanton C. Cancer heterogeneity: implications for targeted therapeutics. British Journal of Cancer 2013 108 479-485. (doi:10.1038/bjc.2012.581)
14. Dalerba P, Cho RW & Clarke MF. Cancer stem cells: models and concepts. Annual Review of Medicine 2007 58 267-284. (doi:10.1146/annurev.med.58.062105.204854)
15. Singh SK, Clarke ID, Hide T & Dirks PB. Cancer stem cells in nervous system tumors. Oncogene 2004 23 7267-7273. (doi:10.1038/sj.onc.1207946)
16. Liu S, Dontu G & Wicha MS. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Research 2005 7 86-95. (doi:10.1186/bcr1021)
17. Wang JC & Dick JE. Cancer stem cells: lessons from leukemia. Trends in Cell Biology 2005 15 494-501. (doi:10.1016/j.tcb.2005.07.004)
18. Mimeault M & Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. Journal of Cellular and Molecular Medicine 2013 17 30-54. (doi:10.1111/jcmm.12004)
19. Lichtenauer UD & Beuschlein F. The tumor stem cell conceptimplications for endocrine tumors? Molecular and Cellular Endocrinology 2009 300 158-163. (doi:10.1016/j.mce.2008.10.037)
20. Feng F, Zhu Y, Wang XJ, Wu YX, Zhou WL, Jin XL, Zhang R, Sun F, Kasoma Z & Shen Z. Predictive factors for malignant pheochromocytoma: analysis of 136 patients. Journal of Urology 2011 185 1583-1589. (doi:10.1016/j.juro.2010.12.050)
21. Lloyd RV, Hardin H, Montemayor-Garcia C, Rotondo F, Syro LV, Horvath E & Kovacs K. Stem cells and cancer stem-like cells in endocrine tissues. Endocrine Pathology 2013 24 1-10. (doi:10.1007/s12022-013-9235-1)
22. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007 318 1917-1920. (doi:10.1126/science.1151526)
23. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Research 2003 63 2244-2250.
24. Alexander RE, Cheng L, Grignon DJ & Idrees M. Cytoplasmic staining of OCT4 is a highly sensitive marker of adrenal medullary-derived tissue. American Journal of Surgical Pathology 2013 37 727-733. (doi:10.1097/PAS.0b013e3182793dc2)
25. Shyh-Chang N & Daley GQ. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell 2013 12 395-406. (doi:10.1016/j.stem.2013.03.005)
26. Lau SK, Romansky SG & Weiss LM. Sustentaculoma: report of a case of a distinctive neoplasm of the adrenal medulla. American Journal of Surgical Pathology 2006 30 268-273. (doi:10.1097/01.pas.0000178095.07513.38)
27. Douwes Dekker PB, Corver WE, Hogendoorn PC, van der Mey AG &Cornelisse CJ. Multiparameter DNA flow-sorting demonstrates diploidy and SDHD wild-type gene retention in the sustentacular cell compartment of head and neck paragangliomas: chief cells are the only neoplastic component. Journal of Pathology 2004 202 456-462. (doi:10.1002/path.1535)
28. Lloyd RV, Blaivas M & Wilson BS. Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues. Archives of Pathology & Laboratory Medicine 1985 109 633-635.
29. Unger P, Hoffman K, Pertsemlidis D, Thung S, Wolfe D & Kaneko M. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas. Archives of Pathology &Laboratory Medicine 1991 115 484-487.
30. Horvath E, Coire CI, Kovacs K & Smyth HS. Folliculo-stellate cells of the human pituitary as adult stem cells: examples of their neoplastic potential. Ultrastructural Pathology 2010 34 133-139. (doi:10.3109/01913121003662247)
31. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J &Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Research 2003 63 5821-5828.
32. Craig W, Kay R, Cutler RL & Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. Journal of Experimental Medicine 1993 177 1331-1342. (doi:10.1084/jem.177.5.1331)
33. Masson NM, Currie IS, Terrace JD, Garden OJ, Parks RW & Ross JA. Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006 291 G45-G54. (doi:10.1152/ajpgi.00465.2005)
34. Rege TA & Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB Journal 2006 20 1045-1054. (doi:10.1096/fj.05-5460rev)
35. Wang YH, Zhao L, Smas C & Sul HS. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Molecular and Cellular Biology 2010 30 3480-3492. (doi:10.1128/MCB.00057-10)
36. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C & Deliliers GL. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Experimental Hematology 2002 30 783-791. (doi:10.1016/S0301-472X(02)00812-3)
37. Sato A, Okumura K, Matsumoto S, Hattori K, Hattori S, Shinohara M &Endo F. Isolation, tissue localization, and cellular characterization of progenitors derived from adult human salivary glands. Cloning and Stem Cells 2007 9 191-205. (doi:10.1089/clo.2006.0054)
38. Loriot C, Burnichon N, Gadessaud N, Vescovo L, Amar L, Libe R, Bertherat J, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP et al. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations. Journal of Clinical Endocrinology and Metabolism 2012 97 E954-E962. (doi:10.1210/jc.2011-3437)